Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
Author:
Affiliation:
1. Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Publisher
Japanese Society for Lymphoreticular Tissue Research
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/jslrt/56/2/56_100/_pdf
Reference51 articles.
1. 1 Pfreundschuh M, Trümper L, Osterborg A, Pettengell R, Trneny M, et al.: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379-391, 2006
2. 2 Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, et al.: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 333:1540-1545, 1995
3. 3 Fisher RI, Miller TP, O’Connor OA: Diffuse aggressive lymphoma. Hematology Am Soc Hematol Educ Program 221-236, 2004
4. 4 Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, et al.: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
5. 5 Sehn LH, Gascoyne RD: Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood 125:22-32, 2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry;Bone Marrow Transplantation;2023-10-07
2. Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials;Leukemia & Lymphoma;2023-08-07
3. Stem Cell Transplant for Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023
4. Stem Cell Transplant for B Cell Non-Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023
5. Cost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis;PLOS ONE;2022-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3